Last update:

Oncology news

New 'smart' nanoparticles help the immune system better attack tumors

Adelaide University researchers have developed a new way to use mRNA technology to reprogram tumor-supporting immune cells and strengthen the body's anticancer immune response.

Cancer is now the leading health threat for 9/11 survivors 25 years on

Twenty-five years after the World Trade Center attacks, cancer has become the defining health problem among survivors who breathed the toxic dust.

Protein linked to cell death may also drive liver cancer

New research from the University of Oklahoma identifies a protein in liver cells that appears to help drive the development of liver cancer associated with obesity-related fatty liver disease. The finding, published in Hepatology, ...

Child cancer groups call for concerted action

It's one of the cruelest ironies in health and medicine. Pediatric sarcomas are among the rarest yet most aggressive forms of childhood cancer and some of the hardest to cure. Whereas many adult cancers are now treatable ...

Trial: Prostate cancer fitness cuts treatment side effects

Findings from STAMINA, the largest trial of its kind, published in The Lancet Oncology, show that a purpose-designed lifestyle program offering structured exercise, dietary advice and behavioral support as part of routine ...

New tool measures thyroid cancer patients' anxiety

A new tool created by Cedars-Sinai Health Sciences University investigators is the first to measure anxiety in patients with thyroid cancer. Described in the journal Thyroid, the Thyroid Cancer Modified Anxiety Scale (TC-MAX) ...

FDA approves first-in-class drug for polycythemia vera

The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals' Mimrylo (rusfertide) as a new treatment for adults with polycythemia vera who have not achieved adequate control with existing therapies.